3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
8
Pancreatic Neoplasms
7
Neoplasms
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Colorectal Neoplasms
3
Stomatitis
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Myofibroma
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Interventions
Geriatric Assessment
4
Nutrition Assessment
2
epigallocatechin gallate
1
cabozantinib
1
Ultrasonography
1
Standard of Care
1
Restraint, Physical
1
Resistance Training
1
Qigong
1
Observation
1
Control Groups
1
Chemotherapy, Adjuvant
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Frailty
×
Ascorbic Acid
×
Clear all
NCT04553666
2026-05-07
ReFOCUS1
University of Rochester
Phase 2
Completed
24 enrolled
17 charts